Reported Jul 8, 2026 · Terminated · Updated Sep 16, 2026
Apheresis Red Blood Cells, Leukocytes Reduced
OneBlood, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: OneBlood, Inc. · 10100 Dr Martin Luther King Jr St N · St Petersburg, FL · 33716-3806
Is this the product you have?
- Apheresis Red Blood Cells, Leukocytes Reduced
- Lot codes and dates
W036825127956 (double collection)W036825488218 (double collection)W036825488220W036825488463 (double collection)W036825488474 (double collection)
- Amount recalled
- 9
This recall covers 4 products
The agency filed one notice per product. You are reading one of them; the other 3 are below.
Where it was sold
Why it was recalled
Apheresis Red Blood Cells, Leukocytes Reduced, which were labeled as leukocytes reduced but were not tested to verify white blood cell count, were distributed.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new OneBlood, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.